Aquestive Therapeutics, Inc AQST

RocketTickers

AQST: Aquestive Therapeutics, Inc. 2021-10-25 08:31:00 Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi

RektNoodle

Wkly falling wedge setting up for a market structure break and rest to start a 5 wave move possibly. looking for a clearance of the Dec 2, 2019 orderblock for long-term growth

Toro_Loco

AQST has broken up from an old downtrend. PT1 - 4.69 PT2 - 5.71

Ale_IT

definitely negative signal for AQST

Investor4321

You guys know I love biotechs with press releases coming up. I also like to wait to enter until the charts look bullish. Aquestive Therapeutics fell from $8 to $4 in September 2020, and I think they could pull back eventually, regardless of press releases. Now that they have an approval coming up on the second, I expect them to perform phenomenally for the rest of...

Jack0

Long idea. could go to 15 if it gets going

simers.co

Both its technical analysis and fundamental reports look great. This is a perfect time to buy this stock.

Marcusll

The market found a line of resistance 4,60. Therefore, the market can rising next days.

Stockwizard23

$spy short AQST

KozakHlib

Contextual immersion trading strategy idea. Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs. The share price rose after good earnings. I see some preconditions the share price will continue growing. The demand for shares of the company still...

UnknownUnicorn6877177

NASDAQ:AQST 😊Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks Our Strategy with this Stock : the company will release the drug for Parkinson disease treatment, The analysts are writing the stock at $17 to drive the sheep to buy the stock , while safe Traders will look for a high price of 6.18 $ . I'm putting two alarms, one at 4.79 to...

JetEquities

AQST: Aquestive Therapeutics, Inc. 2019-11-25 08:00:10 Aquestive Therapeutics Receives FDA Approval for Exservan™ (riluzole) Oral Film

LeeStock

It is very bad to buy now, maybe can buy in few more months later

overwatchtrader

Future Catalyst: 11/18/2018 PDUFA date for tentative approval November 18, 2018. Market cap: 439m Float: 26.4M short float 1.16% NASDAQ:AQST Company Finance: 2.0 Debt / beat EPS, missed on Revs - recent ER Twitter sentiment positive Analyst: Positive NYSE:MNK -2.09%